Literature DB >> 31153981

Prevalence and antibiotic susceptibility of colistin-resistance gene (mcr-1) positive Enterobacteriaceae in stool specimens of patients attending a tertiary care hospital in Singapore.

My-Van La1, Biondi Lee2, Brian Z M Hong3, Jing Yan Yah3, Seok-Hwee Koo4, Boran Jiang5, Lily S Y Ng5, Thean-Yen Tan5.   

Abstract

OBJECTIVES: The aim of this study was to determine the prevalence of the colistin-resistance gene (mcr-1) and the antibiotic-susceptibility profile of mcr-1 positive, colistin-resistant isolates in stool specimens of patients attending a tertiary care hospital in Singapore.
METHODS: 201 diarrheal stool specimens of patients attending the Changi General Hospital between May to August 2017 were collected and screened for the presence of mcr-1 by culture and molecular methods. Antibiotic-susceptibility profile of mcr-1 positive isolates was determined using the polymyxin B and colistin E-tests and the VITEK 2 system.
RESULTS: We observed an unexpectedly high prevalence of mcr-1 in patients attending a tertiary care hospital in Singapore, i.e 6.0% and 8.0% estimated by stool culture and direct stool PCR, respectively. The mcr-1 gene was detected predominantly in Escherichia coli. Antibiotic-susceptibility testing on 12 mcr-1 positive Enterobacteriaceae isolates revealed variable susceptibility profiles with no detection of carbapenem-resistant Enterobacteriaceae.
CONCLUSIONS: This is the first report of the prevalence of human faecal carriage of mcr-1 in Singapore. Our findings highlight the potential risk of mcr-1 spread among our patient cohort. The mcr-1 gene detection combined with the detection of other resistance gene targets of clinical importance is recommended to pre-empt the spread mcr-1 in our patients.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Colistin resistance; Singapore; Stool specimen; mcr-1, human faecal carriage

Mesh:

Substances:

Year:  2019        PMID: 31153981     DOI: 10.1016/j.ijid.2019.05.029

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

Review 1.  Multiresistant Gram-Negative Pathogens—A Zoonotic Problem.

Authors:  Robin Köck; Caroline Herr; Lothar Kreienbrock; Stefan Schwarz; Bernd-Alois Tenhagen; Birgit Walther
Journal:  Dtsch Arztebl Int       Date:  2021-09-06       Impact factor: 5.594

2.  Characterization of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli Isolates from Jurong Lake, Singapore with Whole-Genome-Sequencing.

Authors:  Yang Zhong; Siyao Guo; Kelyn Lee Ghee Seow; Glendon Ong Hong Ming; Joergen Schlundt
Journal:  Int J Environ Res Public Health       Date:  2021-01-22       Impact factor: 3.390

3.  Prevalence and characteristics of multidrug-resistant mcr-1-positive Escherichia coli isolates from broiler chickens in Tai'an, China.

Authors:  Yanying Song; Lanping Yu; Yu Zhang; Yu Dai; Peng Wang; Chenglian Feng; Mengda Liu; Shuhong Sun; Zhijing Xie; Fangkun Wang
Journal:  Poult Sci       Date:  2019-11-29       Impact factor: 3.352

Review 4.  Phage Revolution Against Multidrug-Resistant Clinical Pathogens in Southeast Asia.

Authors:  Mark B Carascal; Donna May Dela Cruz-Papa; Roland Remenyi; Mely Cherrylynne B Cruz; Raul V Destura
Journal:  Front Microbiol       Date:  2022-01-27       Impact factor: 5.640

Review 5.  Worldwide Prevalence of mcr-mediated Colistin-Resistance Escherichia coli in Isolates of Clinical Samples, Healthy Humans, and Livestock-A Systematic Review and Meta-Analysis.

Authors:  Carlos Bastidas-Caldes; Jacobus H de Waard; María Soledad Salgado; María José Villacís; Marco Coral-Almeida; Yoshimasa Yamamoto; Manuel Calvopiña
Journal:  Pathogens       Date:  2022-06-08

6.  Extended-Spectrum β-Lactamase-Producing and mcr-1-Positive Escherichia coli from the Gut Microbiota of Healthy Singaporeans.

Authors:  Yichen Ding; Woei-Yuh Saw; Linda Wei Lin Tan; Don Kyin Nwe Moong; Niranjan Nagarajan; Yik Ying Teo; Henning Seedorf
Journal:  Appl Environ Microbiol       Date:  2021-08-04       Impact factor: 4.792

7.  Evaluation of Vitek®2 performance for colistin susceptibility testing for Gram-negative isolates.

Authors:  Surbhi Khurana; Rajesh Malhotra; Purva Mathur
Journal:  JAC Antimicrob Resist       Date:  2020-12-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.